研究人员创造出超弹性、自我修复材料,将改善人造肌肉

医疗器械 来源:中国科技网 作者:编译:张微
2016
04/20
09:48
中国科技网
作者:编译:张微
医疗器械

如果说这个世界上有完美的实验,那么斯坦福大学化学工程教授Zhenan Bao最近的努力就完全符合要求。

她团队的一位成员,Cheng-Hui Li想要测试他刚刚合成的弹性体的延展性(这种材料是一种橡胶类的塑料)。这种材料通常可以拉伸到其原始长度的两到三倍,还能回弹到它原来的尺度。一个普通的压力测试包括一直拉伸这种弹性体直到超过它的断裂点。

但是Li,一位来自中国的访问学者,遇到了意外的困难:夹具通常测量的弹性只能拉伸到45英寸。想要找到一英寸长的样本的断裂点,Li和另一位实验室成员各持一端,然后各自后退,最后将这个一英寸长的聚合物膜拉伸到100英寸以上。

Bao惊呆了。

“我说,‘这怎么可能?你肯定吗?’”她回忆说。

在今天发表的《自然化学》期刊上,研究人员解释了他们是如何制造这种超弹性物质的。他们还表示,他们可以通过将其暴露在电场中,引起它的扩张和收缩,从而让这个新的弹性体抽动,开发其作为人造肌肉的潜在利用价值。

目前,人造肌肉在消费技术和机器人领域都有应用,但是与真正的肌肉相比,它们有很多缺点,Bao说。目前,用于制造人造肌肉的材料上的小洞或缺陷会让材料失去弹性。如果被刺穿或划伤,它们也无法进行自我修复。

但是这种新材料,除了具有非凡的延展性之外,还具有显着的自愈特性。损坏的聚合物通常需要溶剂或热处理才能恢复性能,但是这种新材料在室温下,即使已经损坏好几天的时间,依然表现出了令人赞叹的自我修复能力。实际上,科研人员发现,它在零下4华氏度(零下20℃)或者在商业冷藏库的温度下也能自我修复。

该团队将新材料的这种非凡的延展性和自我修复能力归因于交叉链接(一种化学粘合法)的一些关键改进。这个过程是指渔网状连接的分子连接成为直链,让聚合物产生了十倍的拉伸能力。

首先,他们设计了一种特殊的有机分子,在交叉链接过程中附着在短聚合物链上,来创造一系列的配体结构。这些配体结合在一起形成长聚合物链——具有内在张力的弹簧圈。

然后,他们在材料中加入金属离子,这些离子对于配体来说具有化学亲和性。当这种复合材料处于受力状态,金属离子和配体之间的化学亲和性就会将网状的分子结构拉紧。其结果就得到了强大的、可伸缩的、自我修复的弹性体。

“聚合物通过金属离子和配体之间的亲和性链接在一起,好像一个大网一样,”Bao解释道。“每一个金属离子至少与两个配体结合,因此,即使一个配体的一端断裂,金属离子仍然可以与配体的另一端相连。当压力被释放时,离子可以很轻松地域另一个配体重新连接,如果它们足够靠近的话。”

研究团队发现,他们可以通过改变金属离子的加入量来调节聚合物,让它变得更有弹性或自愈的更快。这个版本的材料超出了机器的测量范围,例如,通过降低聚合物中铁原子和材料中有机分子的比例就可以创造出新的版本。

研究人员还表明,这种添加金属的新聚合物能够在电场中抽动。他们还要做更多的工作来增加材料的扩张和收缩程度,从而更加精确地控制它。这一研究为未来有前景的应用开启了大门。

除了其作为人造肌肉的长期潜在利用,这项研究还能用于帮助使用假肢的人恢复部分感知能力。在之前的研究中,她的研究团队创造了了灵活但脆性强的聚合物,上面镶有压力传感器,来探测握手和蝴蝶降落的差异。这种新的、耐用材料可以开发成为人造皮肤物理结构的一部分。

“人造皮肤不是由一种材料制成的,”Franziska Lissel说,他是Bao实验室的博士后研究员,也是该研究团队的成员。“我们想要创造一个非常复杂的系统。”

即使在人造肌肉和人工皮肤变成实用性技术之前,这项工作也非常重要,强大、灵活和电子活性聚合物的开发,能够引发新一代的可穿戴电子产品,或者能够制造使用很长时间不需要修理或更换的医疗植入物。

Researchers create super stretchy, self-healing material that could lead to artificial muscle

If there's such a thing as an experiment that goes too well, a recent effort in the lab of Stanford chemical engineering Professor Zhenan Bao might fit the bill.

One of her team members, Cheng-Hui Li, wanted to test the stretchiness of a rubberlike type of plastic known as an elastomer that he had just synthesized. Such materials can normally be stretched two or three times their original length and spring back to original size. One common stress test involves stretching an elastomer beyond this point until it snaps.

But Li, a visiting scholar from China, hit a snag: The clamping machine typically used to measure elasticity could only stretch about 45 inches. To find the breaking point of their one-inch sample, Li and another lab member had to hold opposing ends in their hands, standing further and further apart, eventually stretching a 1-inch polymer film to more than 100 inches.

Bao was stunned.

“I said, 'How can that be possible? Are you sure?‘” she recalled.

Today in Nature Chemistry, the researchers explain how they made this super-stretchy substance. They also showed that they could make this new elastomer twitch by exposing it to an electric field, causing it to expand and contract, making it potentially useful as an artificial muscle.

Artificial muscles currently have applications in some consumer technology and robotics, but they have shortcomings compared to a real bicep, Bao said. Small holes or defects in the materials currently used to make artificial muscle can rob them of their resilience. Nor are they able to self-repair if punctured or scratched.

But this new material, in addition to being extraordinarily stretchy, has remarkable self-healing characteristics. Damaged polymers typically require a solvent or heat treatment to restore their properties, but the new material showed a remarkable ability to heal itself at room temperature, even if the damaged pieces are aged for days. Indeed, researchers found that it could self-repair at temperatures as low as negative 4 degrees Fahrenheit (-20 C), or about as cold as a commercial walk-in freezer.

The team attributes the extreme stretching and self-healing ability of their new material to some critical improvements to a type of chemical bonding process known as crosslinking. This process, which involves connecting linear chains of linked molecules in a sort of fishnet pattern, has previously yielded a tenfold stretch in polymers.

First they designed special organic molecules to attach to the short polymer strands in their crosslink to create a series of structure called ligands. These ligands joined together to form longer polymer chains – spring-like coils with inherent stretchiness.

Then they added to the material metal ions, which have a chemical affinity for the ligands. When this combined material is strained, the knots loosen and allow the ligands to separate. But when relaxed, the affinity between the metal ions and the ligands pulls the fishnet taut. The result is a strong, stretchable and self-repairing elastomer.

“Basically the polymers become linked together like a big net through the metal ions and the ligands,” Bao explained. “Each metal ion binds to at least two ligands, so if one ligand breaks away on one side, the metal ion may still be connected to a ligand on the other side. And when the stress is released, the ion can readily reconnect with another ligand if it is close enough.”

The team found that they could tune the polymer to be stretchier or heal faster by varying the amount or type of metal ion included. The version that exceeded the measuring machine's limits, for example, was created by decreasing the ratio of iron atoms to the polymers and organic molecules in the material.

The researchers also showed that this new polymer with the metal additives would twitch in response to an electric field. They have to do more work to increase the degree to which the material expands and contracts and control it more precisely. But this observation opens the door to promising applications.

In addition to its long-term potential for use as artificial muscle, this research dovetails with Bao's efforts to create artificial skin that might be used to restore some sensory capabilities to people with prosthetic limbs. In previous studies her team has created flexible but fragile polymers, studded with pressure sensors to detect the difference between a handshake and a butterfly landing. This new, durable material could form part of the physical structure of a fully developed artificial skin.

“Artificial skin is not just made of one material,” said Franziska Lissel, a postdoctoral fellow in Bao's lab and member of the research team. “We want to create a very complex system.”

Even before artificial muscle and artificial skin become practical, this work in the development of strong, flexible, electronically active polymers could spawn a new generation of wearable electronics, or medical implants that would last a long time without being repaired or replaced.

来源:中国科技网   作者:编译:张微

为你推荐

“向光而生·同心前行”2026年世界癌症日特别活动在沪举办资讯

“向光而生·同心前行”2026年世界癌症日特别活动在沪举办

以患者为中心,多方携手共绘癌症科学诊疗新蓝图

2026-02-04 13:13

合成生物企业桦冠生物宣布完成数亿元C轮融资资讯

合成生物企业桦冠生物宣布完成数亿元C轮融资

本轮融资由软银欣创、顺禧基金、常州启航合成生物创投基金、国投创益、长江资本等多家知名机构联合投资,光源资本担任财务顾问,所融资金将重点投向医药与大健康领域新品研发、...

2026-02-04 11:50

AI制药独角兽深度智耀完成6000万美元新一轮融资,加速全栈式研发解决方案落地资讯

AI制药独角兽深度智耀完成6000万美元新一轮融资,加速全栈式研发解决方案落地

本轮融资吸引了信宸资本、金镒资本、凯泰资本等新投资方入局,老股东鼎晖百孚、新鼎资本持续追加投资

2026-02-03 20:03

济川药业联合康方生物,共拓心血管创新药商业化新局资讯

济川药业联合康方生物,共拓心血管创新药商业化新局

伊喜宁®(伊努西单抗注射液)是康方生物自主开发创新的PCSK9单克隆抗体新药,于2024年9月获批上市,用于治疗原发性高胆固醇血症和混合型高脂血症,包括杂合子家族性高胆固醇血...

2026-02-03 19:34

华东医药创新药罗氟司特乳膏0.05%特应性皮炎适应症申报上市资讯

华东医药创新药罗氟司特乳膏0.05%特应性皮炎适应症申报上市

适用于2岁至5岁轻度至中度特应性皮炎患者的局部外用治疗

2026-02-03 19:29

拜耳诺倍戈®第三项适应症在中国获批,用于治疗转移性激素敏感性前列腺癌(mHSPC)

诺倍戈®此前已先后获批用于治疗有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者,和联合多西他赛治疗转移性激素敏感性前列腺癌的(mHSPC)成年患者。

2026-02-03 18:42

第101批仿制药参比制剂目录资讯

第101批仿制药参比制剂目录

经国家药品监督管理局仿制药质量和疗效一致性评价专家委员会审核确定,现发布仿制药参比制剂目录(第一百零一批)。

2026-02-03 13:19

支付宝集五福2月3日0点开启,新增“健康福”资讯

支付宝集五福2月3日0点开启,新增“健康福”

2月3日0点,一年一度的春节“支付宝集福”活动将正式上线,活动将持续至除夕夜。

2026-02-02 14:27

又一款老花眼滴眼液获批,市场有待检验资讯

又一款老花眼滴眼液获批,市场有待检验

近日,Tenpoint Therapeutics宣布,美国FDA已批准Yuvezzi(carbachol和brimonidine tartrate滴眼液,2 75% 0 1%),用于治疗成人老花眼。

2026-02-02 14:06

深度缓解数据惊艳:基于诺奖机制的 CELMoD药物如何重塑 MM 治疗逻辑?  资讯

深度缓解数据惊艳:基于诺奖机制的 CELMoD药物如何重塑 MM 治疗逻辑?

近期,国家药品监督管理局药品审评中心(CDE)将CELMoD药物 iberdomide (以下简称:IBER)纳入优先审评名单并启动优先审评程序,拟批准

2026-02-02 13:22

今日起,医疗药品、保健食品、特殊医学用途配方食品、医疗器械难以电商直播资讯

今日起,医疗药品、保健食品、特殊医学用途配方食品、医疗器械难以电商直播

2月1日,《直播电商监督管理办法》正式实施。

2026-02-01 14:14

儿童生长发育专业、儿童营养专业、儿童皮肤疾病专业纳入北京互联网诊疗首诊试点资讯

儿童生长发育专业、儿童营养专业、儿童皮肤疾病专业纳入北京互联网诊疗首诊试点

经研究,同意你委依托首都医科大学附属北京儿童医院和首都医科大学附属首都儿童医学中心开展儿童生长发育专业、儿童营养专业、儿童皮肤疾病专业互联网诊疗首诊试点。

2026-01-31 23:34

诺和诺德大中国区换帅:周霞萍3月底离任,“老兵”蔡琰接棒资讯

诺和诺德大中国区换帅:周霞萍3月底离任,“老兵”蔡琰接棒

1月30日,全球制药巨头诺和诺德正式对外宣布重大人事变动,其全球高级副总裁兼大中国区总裁周霞萍决定离开公司,最后工作日为2026年3月31日

2026-01-31 17:36

思璞锐SciBrunch完成超3500万美元Pre-A轮融资,一年内两轮合计募资6500万美元资讯

思璞锐SciBrunch完成超3500万美元Pre-A轮融资,一年内两轮合计募资6500万美元

本次Pre-A轮融资由生物医药领域知名投资机构弘晖基金(HLC)领投,InnoPinnacle Fund跟投,同时获得老股东汉康资本、博远资本、LongRiver江远投资及骊宸投资的持续加码支持。

2026-01-31 17:30

因美纳完成对SomaLogic的收购资讯

因美纳完成对SomaLogic的收购

双方整合将为蛋白质分析带来更高的可扩展性、灵活性与性价比

2026-01-30 22:18

阿斯利康宣布将于2030年前在华投资逾1000亿元人民币,与石药集团达成超百亿美元战略合作资讯

阿斯利康宣布将于2030年前在华投资逾1000亿元人民币,与石药集团达成超百亿美元战略合作

1月29日,阿斯利康宣布,计划于2030年前在中国投资逾1000亿元人民币(150亿美元),以扩大在药品生产与研发领域的布局。公司将充分发挥中国的科研优势和先进制造能力,并依托中...

2026-01-30 13:00

从“无差别轰炸”到“定点爆破”,我国二线HER2阳性胃癌治疗迎来靶向ADC新突破资讯

从“无差别轰炸”到“定点爆破”,我国二线HER2阳性胃癌治疗迎来靶向ADC新突破

近日,优赫得®(注射用德曲妥珠单抗)正式获得中国国家药品监督管理局(NMPA)批准,单药用于治疗既往接受过一种含曲妥珠单抗治疗方案的局部晚期或转移性HER2阳性成人胃或胃食...

2026-01-29 18:54

18个区域,中医优势病种按病种付费试点地区明确资讯

18个区域,中医优势病种按病种付费试点地区明确

根据《关于开展中医优势病种按病种付费试点工作的通知》要求,国家医保局、国家中医药局组织专家对申报中医优势病种按病种付费试点的地区开展遴选,经相应程序,确定北京、河北...

2026-01-29 18:16

合成生物创新企业康诺生物递交港交所上市申请资讯

合成生物创新企业康诺生物递交港交所上市申请

康诺生物核心业务聚焦于线粒体功能障碍相关疾病的研究,专注于NAD+抗心血管疾病、NAD+抗生殖功能障碍、NAD+抗神经退行性疾病和NAD+抗衰老等领域的科学应用

2026-01-29 18:15